Surgical treatment of lymph node metastases in stage IB cervical cancer: The laterally extended parametrectomy (LEP) procedure

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A surgical method has been introduced for the treatment of early stage cervical cancer patients with pelvic lymph node metastases. The procedure was used without any adjuvant treatment in 31 stage IB cervical cancer patients, where pelvic lymph node metastases were proven by intraoperative histology. Two patients were lost for follow-up. Twenty-nine patients were followed up for 24-105 months (mean 60 months). Twenty-five of 29 patients were alive and disease-free at the end of the study period. Kaplan-Meier 5 years cumulative proportion survival was 85% (SE 7%). Complications in four cases (16%) necessitated a second operation. One patient developed treatment-refractory grade II incontinence. All but the one incontinent patient are alive without significant treatment related symptoms. The results suggest that pelvic lymph node metastases can be cured by surgery alone. The LEP procedure seems to be a treatment alternative to chemoradiotherapy for early stage cervical cancer patients with pelvic lymph node metastases.

Original languageEnglish
Pages (from-to)647-651
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume13
Issue number5
DOIs
Publication statusPublished - Sep 2003

Fingerprint

Uterine Cervical Neoplasms
Lymph Nodes
Neoplasm Metastasis
Therapeutics
Chemoradiotherapy
Histology
Survival

Keywords

  • Cervical cancer
  • Extended parametrectomy
  • Lymph node metastasis

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Cancer Research

Cite this

@article{df77becb49b5467c9dc371b41afccc8a,
title = "Surgical treatment of lymph node metastases in stage IB cervical cancer: The laterally extended parametrectomy (LEP) procedure",
abstract = "A surgical method has been introduced for the treatment of early stage cervical cancer patients with pelvic lymph node metastases. The procedure was used without any adjuvant treatment in 31 stage IB cervical cancer patients, where pelvic lymph node metastases were proven by intraoperative histology. Two patients were lost for follow-up. Twenty-nine patients were followed up for 24-105 months (mean 60 months). Twenty-five of 29 patients were alive and disease-free at the end of the study period. Kaplan-Meier 5 years cumulative proportion survival was 85{\%} (SE 7{\%}). Complications in four cases (16{\%}) necessitated a second operation. One patient developed treatment-refractory grade II incontinence. All but the one incontinent patient are alive without significant treatment related symptoms. The results suggest that pelvic lymph node metastases can be cured by surgery alone. The LEP procedure seems to be a treatment alternative to chemoradiotherapy for early stage cervical cancer patients with pelvic lymph node metastases.",
keywords = "Cervical cancer, Extended parametrectomy, Lymph node metastasis",
author = "L. Ung{\'a}r and L. P{\'a}lfalvi",
year = "2003",
month = "9",
doi = "10.1046/j.1525-1438.2003.13377.x",
language = "English",
volume = "13",
pages = "647--651",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Surgical treatment of lymph node metastases in stage IB cervical cancer

T2 - The laterally extended parametrectomy (LEP) procedure

AU - Ungár, L.

AU - Pálfalvi, L.

PY - 2003/9

Y1 - 2003/9

N2 - A surgical method has been introduced for the treatment of early stage cervical cancer patients with pelvic lymph node metastases. The procedure was used without any adjuvant treatment in 31 stage IB cervical cancer patients, where pelvic lymph node metastases were proven by intraoperative histology. Two patients were lost for follow-up. Twenty-nine patients were followed up for 24-105 months (mean 60 months). Twenty-five of 29 patients were alive and disease-free at the end of the study period. Kaplan-Meier 5 years cumulative proportion survival was 85% (SE 7%). Complications in four cases (16%) necessitated a second operation. One patient developed treatment-refractory grade II incontinence. All but the one incontinent patient are alive without significant treatment related symptoms. The results suggest that pelvic lymph node metastases can be cured by surgery alone. The LEP procedure seems to be a treatment alternative to chemoradiotherapy for early stage cervical cancer patients with pelvic lymph node metastases.

AB - A surgical method has been introduced for the treatment of early stage cervical cancer patients with pelvic lymph node metastases. The procedure was used without any adjuvant treatment in 31 stage IB cervical cancer patients, where pelvic lymph node metastases were proven by intraoperative histology. Two patients were lost for follow-up. Twenty-nine patients were followed up for 24-105 months (mean 60 months). Twenty-five of 29 patients were alive and disease-free at the end of the study period. Kaplan-Meier 5 years cumulative proportion survival was 85% (SE 7%). Complications in four cases (16%) necessitated a second operation. One patient developed treatment-refractory grade II incontinence. All but the one incontinent patient are alive without significant treatment related symptoms. The results suggest that pelvic lymph node metastases can be cured by surgery alone. The LEP procedure seems to be a treatment alternative to chemoradiotherapy for early stage cervical cancer patients with pelvic lymph node metastases.

KW - Cervical cancer

KW - Extended parametrectomy

KW - Lymph node metastasis

UR - http://www.scopus.com/inward/record.url?scp=1242269314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242269314&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1438.2003.13377.x

DO - 10.1046/j.1525-1438.2003.13377.x

M3 - Article

C2 - 14675349

AN - SCOPUS:1242269314

VL - 13

SP - 647

EP - 651

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 5

ER -